; and (4) engage with international partners and strategic allies to share best practices and coordinate prediction and modeling of infectious disease. (e) Coordination with national academies standing committee on emerging infectious disease and 21st century health threats The Director of the Office of Science and Technology Policy shall coordinate with the National Academies to ensure that at least one member of the interagency working group is also a member of the committee under section 4. (f) Biennial reporting One years after the date of enactment of this Act, and at least every 2 years thereafter, the Director of the Office of Science and Technology Policy shall provide a summary report to Congress on the activities of the working group. 4. National Academies Standing Committee on Emerging Infectious Disease and 21st Century Health Threats (a) In general The Office of Science and Technology Policy, and other agencies as determined by the Director of the Office of Science and Technology Policy, shall enter into an agreement with the National Academies to create a Standing Committee on Emerging Infectious Disease and 21st Century Health Threats (hereinafter in this section referred to as the Standing Committee ). (b) Participants The Standing Committee shall include members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. (c) Purpose The purpose of the Standing Committee is to facilitate the exchange of ideas among Federal agencies, the private sector, and the academic community, as well as other relevant stakeholders, including— (1) responding on short notice to requests from the Federal Government to assess and consider the science and policy implications of an emerging infectious disease or significant public health threat